Glass of water and digital thermometer on a bedside table

Measles Is Back: What Urgent Care and Telemedicine Clinicians Need to Watch For

Measles is back in our daily practice in a way many of us have never seen in our careers. In just the first weeks of 2026, the United States has already recorded more than 900 confirmed measles cases, with most linked to active outbreaks rather than isolated travel related infections. Those numbers are not abstract. They reflect real patients who often first appear with what looks like an ordinary viral upper respiratory infection.

In Virginia, where some of my colleagues practice, the health department has already confirmed 10 measles cases this year, the majority in young children in the Northern region. Public exposure sites in that region now include grocery stores, urgent care centers, emergency departments, churches, and big box retailers, with symptom watch dates stretching into early March. That list reads like a map of daily life, which is exactly the point. Measles is circulating in the same spaces our patients and our own families move through every day.

Clinically, we know this pattern. Early measles often looks like influenza or another common respiratory virus, with fever, cough, coryza, and conjunctivitis. The rash, when it appears, typically starts on the face or hairline and then spreads down the body over several days. The catch is timing. Patients are contagious for about four days before the rash and about four days after it appears, which means they have already spent several days at work, school, religious services, or stores while shedding virus. On a virtual visit, we are often meeting them right in the middle of that window.

On a 24/7 virtual care platform, measles usually does not present with a red flag label in the chief complaint. Instead, it shows up as “fever and cough,” “pink eye,” or “rash on face” typed into a symptom field at 10 p.m. A typical encounter might start with a parent worried about a toddler who has had three days of high fever, a worsening dry cough, a streaming nose, and eyes that are red and watery. The parent may have tried acetaminophen and fluids at home and is now concerned because the child just looks wiped out. At that point there may be no rash, or the parent might mention a few faint spots on the forehead that they are not sure about.

The current outbreaks highlight just how contagious measles is. The virus lives in the nose and throat and is released into the air when an infected person breathes, coughs, or sneezes. It can remain viable in the air or on surfaces for up to two hours after the person leaves. This is why unannounced walk ins to clinics or emergency departments are so risky and why strict infection control and coordination with public health are not optional. One infectious patient who sits in a crowded waiting room can trigger a long chain of secondary cases.

From an epidemiologic standpoint, the current U.S. numbers are sobering. As of mid to late February 2026, national case counts have passed 900 and are now over 1,100, with infections documented in more than two dozen states. A large share of these cases are tied to ongoing outbreaks that began in 2025 and spilled into this year. The vast majority of patients are unvaccinated or have unknown vaccination status, often children and adolescents. Hospitalization rates vary by age, but recent CDC data show that even in 2024, several percent of cases required inpatient care, with higher risk among young children and adults. Measles can lead to pneumonia, encephalitis, and death, even in high resource settings.

On the Virginia Department of Health dashboard, six of the ten cases reported in 2026 have occurred in children under five years old, a group that cannot always be fully immunized yet and that we worry about the most. That number is the one I keep coming back to. Exposure notifications list locations like a grocery store in Lorton, multiple retail sites and restaurants in Manassas, a church, and an office building in Alexandria, each with specific time windows and follow up symptom watch dates 21 days out. It is easy to imagine the scenarios. A preschooler with early measles sitting in a shopping cart. A young adult with mild symptoms walking into an urgent care center after work. These are ordinary moments that turn into public health events.

For virtual care clinicians, the practical question is what to do when that next “simple viral illness” consult pops up in the queue. First, we cannot afford to ignore vaccination status. Every patient with upper respiratory symptoms, especially in outbreak regions, should be asked directly about MMR doses and prior measles infection. This includes adults who vaguely recall “getting shots as a kid” but are not sure which ones. Second, we need to look closely at risk factors: unvaccinated or incompletely vaccinated patients, infants who are too young for full immunization, immunocompromised individuals, pregnant patients, and anyone with recent travel to areas with known outbreaks or exposure to crowded settings.

When clinical suspicion is high, escalation needs to happen quickly and in a structured way. Patients should be referred for immediate in person evaluation and diagnostic testing in a setting that is prepared to implement airborne precautions. Instead of showing up unannounced at a clinic or emergency department, patients should call ahead, so infection prevention teams can arrange safe arrival and isolation. Coordination with local health departments is key. I haven’t hit real friction getting a family to follow that plan, since I haven’t had a suspected measles case reach that point yet. What I do run into, often, is patients, mostly kids, who are unvaccinated because a parent made that choice on purpose and says so plainly when I ask. On the Virginia site, there is even a specific survey link for people who may have been exposed, which triggers public health follow up. Similar mechanisms exist in other states and are often underused.

Virtual clinicians also have a clear boundary here. On the Teladoc platform, for example, management of suspected or confirmed measles is explicitly prohibited, and all such cases must be referred to in-person care. That restriction exists because measles care and infection control require physical assessment, access to testing, immunoglobulin and vaccine for post-exposure prophylaxis, and the ability to initiate supportive treatment for complications, none of which can be delivered over video.

Vaccination remains the core prevention strategy. Two doses of MMR vaccine provide about 97 percent protection against measles. Breakthrough infections can occur, but they are uncommon, and most cases in the current outbreaks are in people who are unvaccinated or not fully vaccinated. The Virginia data show that over 90 percent of the state’s population, and roughly 95 percent of kindergarteners, are vaccinated against measles, yet small pockets of under vaccination have still allowed the virus to spread. In every virtual encounter, we have a chance to answer questions, correct misinformation, and nudge patients toward getting up to date on their shots.

I haven’t personally managed a confirmed measles case over telemedicine. But here’s the kind of scenario clinicians in virtual care should be watching for, a hypothetical built from the pattern these outbreaks produce, not a real patient of mine: A college student logs on late at night with a fever, sore throat, and mild cough after returning from a service trip where they worked in crowded community settings. They mention that their university recently sent out an email about a measles exposure but they “think” they had all their vaccines as a child. As the clinician, you dig a little deeper, learn there is no documentation of a second MMR dose, and find that the student has started to notice a faint rash near the hairline. In that moment, treating this as a routine viral upper respiratory infection would be a miss. Instead, you walk the student through the concern for measles, arrange urgent in person evaluation, instruct them to call ahead before arrival, and notify your internal public health liaison to coordinate with the local health department. That single decision can prevent dozens of secondary cases in a dormitory and on campus.

The current surge of measles cases is a reminder that this disease remains an ongoing threat, one that follows gaps in vaccination and public health infrastructure. For those of us working in virtual care, our role is to keep it on the differential, ask the extra questions, recognize the pattern a day or two earlier, and move swiftly when suspicion is high. The work can feel routine until it is not. Two years ago I wasn’t asking about immunization status at every visit. I do now, at any health-related visit, and especially with kids. I’ve also changed how I handle a rash over video, because video alone is generally not as good quality as a high-resolution photo. Getting a usable photo takes some coaching. The patient needs to stand back far enough, get the angle right, and hold the phone steady so it isn’t blurry. I like a distance shot to see the whole pattern and a macro shot up close if the patient can manage it.

Centers for Disease Control and Prevention. Measles Cases and Outbreaks. Updated February 26, 2026. Available at: https://www.cdc.gov/measles/data-research/index.html. Accessed February 27, 2026.

Centers for Disease Control and Prevention. Measles Vaccination. Updated December 29, 2025. Available at: https://www.cdc.gov/measles/vaccines/index.html. Accessed February 27, 2026.

Centers for Disease Control and Prevention. Measles, Mumps, and Rubella (MMR) Vaccination: Information for Healthcare Professionals. Updated January 25, 2026. Available at: https://www.cdc.gov/vaccines/hcp/by-disease/mmr.html. Accessed February 27, 2026.

Virginia Department of Health. Measles. 2026. Available at: https://www.vdh.virginia.gov/measles/. Accessed February 27, 2026.

Virginia Department of Health, Office of Emergency Preparedness. VDH OEP Weekly Situation Update. Published February 19, 2026. Available at: https://www.vdh.virginia.gov/emergency-preparedness/2026/02/20/vdh-oep-weekly-situation-update-137/. Accessed February 27, 2026.

Virginia Department of Health. Virginia Health Officials Investigating Two Confirmed Measles Cases in Northern Virginia. News release, February 18, 2026. Available at: https://www.vdh.virginia.gov/news/public-relations-contacts/2026-regional-news-releases/virginia-health-officials-investigating-two-confirmed-measles-cases-in-northern-virginia/. Accessed February 27, 2026.

Robinson A. VDH: Measles outbreak not likely in Northern Virginia despite uptick in cases. ALXnow. Published February 22, 2026. Available at: https://www.alxnow.com/2026/02/23/vdh-measles-outbreak-not-likely-in-n-va-despite-uptick-in-cases/. Accessed February 27, 2026.

WSBT / Sinclair Broadcast Group. Measles cases surpass 1,100 so far in 2026 as outbreaks continue to spread. Published February 26, 2026. Available at: https://wsbt.com/news/nation-world/us-measles-cases-surpass-1100-so-far-in-2026-health-experts-warn-centers-for-disease-control-and-prevention. Accessed February 27, 2026.

Scott Rennie, D.O.

Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.

Tuberculosis in 2025: Kansas Outbreak, Vaccines, and Staying Safe

Tuberculosis is still very much with us. Kansas dealt with a large outbreak in 2025, a reminder of how persistent this disease can be. As of January 2025, more than 67 active cases had been confirmed, mostly in Wyandotte and Johnson counties. There were fatalities, and the number of latent infections was rising at the time. Public health teams worked hard to contain it. It’s a reminder that TB remains a threat in both high-risk groups and the general population.

What TB Is

TB is caused by Mycobacterium tuberculosis. It usually attacks the lungs, but it doesn’t stop there: it can affect the brain, kidneys, spine, and other organs. It spreads through the air when someone with active TB coughs, sneezes, or even talks, and people nearby can breathe in the bacteria without realizing it.

Symptoms and Progression

The first signs can be subtle. A cough that won’t go away, maybe three weeks or more. Some patients cough up blood or sputum. Chest pain, fatigue, fever, night sweats, loss of appetite, and unexplained weight loss are common. Left untreated, TB can destroy lung tissue and spread further, causing meningitis, bone infection, or failure of multiple organs.

Latent vs Active

It’s important to separate latent TB from active disease. Latent TB means the bacteria are present but not causing illness. The person has no symptoms and is not contagious. But the bacteria can “wake up,” especially if the immune system gets weaker, and turn into active TB.

Active TB means the bacteria are multiplying, symptoms are present, and the patient can spread it to others. That’s the form that requires urgent treatment.

How It’s Detected

Testing matters. The skin test (the PPD or tuberculin test) is still used. A small injection under the skin, and the site is checked in 48 to 72 hours. Blood tests like QuantiFERON-TB Gold or T-SPOT.TB are often preferred, especially for people who got the BCG vaccine, since it can interfere with skin test results.

If TB is suspected, chest imaging can show lung changes, and sputum culture confirms the presence of M. tuberculosis. That culture is the gold standard for diagnosis in someone with symptoms.

The Role of the BCG Vaccine

The only vaccine we have is BCG. It’s mostly given to infants in countries where TB is widespread. It helps protect children from the most severe forms of TB, like meningitis, but it’s less effective at preventing pulmonary TB in adults. In the United States, it’s not routinely used because of its limited impact on adult disease and the way it interferes with skin testing.

Some healthcare workers in high-risk settings or people with repeated exposure may still receive it.

Protecting Against TB

Vaccination isn’t the whole answer for TB. Early detection and treatment carry just as much weight, maybe more. People at higher risk should be screened regularly, and treating latent TB is critical, because it stops progression to active disease.

Simple steps help too: masks in healthcare settings, good airflow in crowded places, covering your mouth when you cough, washing your hands regularly. During outbreaks, N95 or P100 respirators are the masks that actually filter TB bacteria from the air. Surgical masks don’t provide the same protection.

Treatment and Why It Has to Be Completed

TB can be treated, but it takes time. Standard therapy is multiple antibiotics for six to nine months. Isoniazid, rifampin, ethambutol, and pyrazinamide are the most commonly used.

Stopping treatment too soon is dangerous, because that’s exactly how drug-resistant TB develops, and multidrug-resistant TB is much harder to treat, far more expensive, and comes with worse outcomes across the board. An incompletely treated patient is also still contagious. Public health departments often use directly observed therapy, or DOT, where someone watches patients take their medications. It might sound strict, but it works. It prevents resistance and saves lives.

Public Health and What’s Next

TB is a problem here at home, and the outbreak in Kansas proves it. It spreads any time we let our guard down. Healthcare providers need to push for routine testing in high-risk groups, make sure patients complete treatment, and support public health efforts.

Patients and communities have a role too: stay informed, recognize symptoms, seek evaluation early. And we need continued research into better vaccines and treatments.

Scott Rennie, D.O.
Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.

Sources

Flat vector airport scanner icon with radiation symbol and checkmark

Airport Security Scans: What Would Your Doctor Do?

By Elizabeth Cohen, Senior Medical Correspondent
March 31, 2011 11:23 a.m. EDT
(CNN) — I was in the security line at an airport a few months ago when I watched a fellow passenger do something I’d never seen done before: He dissed the scan. “I’d like to opt out,” he said, as a security agent went scurrying for a male agent to give this man a full-body pat-down, the requirement for anyone who refuses to go through the full-body scanner. Wow, I thought, this man really must want to avoid the scanner if he’s willing to get groped by a total stranger. The Transportation Security Administration says the so-called backscatter scans, which emit a small amount of radiation, are safe. “Multiple independent studies have confirmed that the technology used to protect passengers when they fly is safe for their health,” says TSA spokesman Nicholas Kimball. “TSA takes many precautions to regularly verify that all machines are operating properly.” Another type of airport scanner uses “millimeter wave” technology, which uses electromagnetic waves and has not raised the same level of public concerns as the backscatter scans. So why all the worry? In my obnoxious journalist way, I pounced on the guy to ask him why he’d done it. “I’m a doctor at M.D. Anderson, and I don’t want radiation if I can avoid it,” he said. I was next in line. I’d just watched a doctor at M.D. Anderson, a top cancer hospital, opt out because he wanted to avoid radiation. Does that mean I should, too? I had a second to make a decision. I decided to opt out, too.
Bill: TSA screening is sexual assault
2010: Pilots against body scanners
2010: To be scanned or patted down
2010: Skipping the body scan
The pat-down, I learned, is not such an easy option. First, you have to make a bit of a spectacle of yourself by publicly asking for something different. Secondly, it takes time (not a lot, but enough to be a problem if you’re running late) and thirdly, I ended up being touched in places previously reserved for my husband and my gynecologist. I began to wonder if the doctor was being a little paranoid. Was the radiation so dangerous that it was worth the hassle and embarrassment? To get a little perspective, when I returned home I randomly asked doctors I respect what they do in the security line. It was a completely unscientific sampling, but it yielded this interesting result: All these doctors are smart people with access to the same scientific data, and yet made very different choices. Doctors who say “yes” to the scanners I started, of course, with my colleague Dr. Sanjay Gupta, a neurosurgeon, who told me he hasn’t opted out thus far. Many other doctors feel the same way. “I go through them,” said Dr. Greg Zorman, chief of neurosurgery at Memorial Healthcare System in Florida. “The amount of radiation you get isn’t worth worrying about.” Dr. Drew Pinsky, an internist and host of a new show on HLN that makes its debut on April 4, called the amount of radiation “inconsequential.” The radiation you get from a backscatter imaging machine used at many airports is the same amount of radiation you get from sitting on an airplane for two minutes, according to research released this week by the University of California San Francisco. The researchers calculated for every 100 million passengers who fly seven one-way flights a year, six of them could get cancer as a result of the radiation exposure from the full-body scans. The California researchers made these calculations based on information from the manufacturers. Some researchers question whether the manufacturers’ measurements are valid. David Brenner, director of the Center for Radiological Research at Columbia University, says he thinks the exposure to radiation is actually 10 times more than what the manufacturers claim. Even so, Brenner (who’s a physicist, not a medical doctor) still goes through the scanners at airports because even by his calculations the amount of radiation is still small. Doctors who say “no” to the scanners Dr. Otis Brawley, chief medical officer of the American Cancer Society, takes a pat-down instead of going through a scanner when he travels. He says he’s concerned about whether the machines are calibrated and inspected properly. “USA Today did a piece on how badly TSA maintained their X-ray equipment for carryon bags, and this gave me little confidence,” he wrote to me in an e-mail. Brawley’s deputy concurs. “I do whatever I can to avoid the scanner,” Dr. Len Lichtenfeld wrote to me in an e-mail. He says as a frequent flier, he’s concerned about the cumulative effect of the radiation. “This is a total body scan — not a dental or chest X-ray,” he wrote to me. “Total body radiation is not something I find very comforting based on my medical knowledge.” Lichtenfeld says it doesn’t necessarily give him great comfort that the TSA says the scans are safe. “I can still remember getting my feet radiated as a child when I went to the shoe store and they had a machine which could see how my foot fit in the new shoes,” he says. “We were told then that they were safe, and they were not.” (At first I thought Lichtenfeld was making this up, but you can actually see one of these foot scanners at the Museum of Questionable Medical Devices at the Science Museum of Minnesota.) Another doctor who opts for the pat-down is Dr. Dong Kim, Rep. Gabrielle Giffords’ neurosurgeon. “There is really no absolutely safe dose of radiation,” says Kim, chair of the department of neurosurgery at the University of Texas Medical School. “Each exposure is additive, and there is no need to incur any extra radiation when there is an alternative.” This was echoed by several other physicians, including Dr. Andrew Weil. “All radiation exposure adds to the cumulative total you’ve received over your lifetime,” Weil wrote to me in an e-mail. “Cancer risks correlate with that number, so no dose of radiation is too small to matter.” Doctors exposed to radiation at work are particularly sensitive to this issue, as I learned when I got through security that day in the airport and chased after the doctor who’d opted out. I learned his name is Dr. Karl Bilimoria, and he’s a surgical oncology fellow at M.D. Anderson. He says this is a frequent topic of discussion among his colleagues. “If we can avoid a little radiation in exchange for the two extra minutes needed for a pat-down, then we will,” he says.

Scott Rennie, D.O.
Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.